Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
about
Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat.Treatment of nonalcoholic steatohepatitis in adults: present and futureInfluence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetesMicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes.Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline.Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.Protein phosphatase 4 interacts with and down-regulates insulin receptor substrate 4 following tumor necrosis factor-alpha stimulation.Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary diseaseSerum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus.MicroRNAs in β-cell biology, insulin resistance, diabetes and its complicationsEffects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J miceAdipose tissue and atherothrombosis.Tumor necrosis factor-alpha, biologic agents and cardiovascular risk.Review article: Drug therapy for non-alcoholic fatty liver disease.The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance?Changing the energy of an immune responseFasting and postprandial markers of inflammation in lean and overweight children.Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations.Loss of the TNFα function inhibits Wnt/β-catenin signaling, exacerbates obesity development in adolescent spontaneous obese mice.Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era.Oral nucleic acid therapy using multicompartmental delivery systems.Attenuation of influenza virus infectivity with herbal-marine compound (HESA-A): an in vitro study in MDCK cells.Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus.An autocrine/paracrine loop linking keratin 14 aggregates to tumor necrosis factor alpha-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex.Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.Platelet-rich plasma inhibits the apoptosis of highly adipogenic homogeneous preadipocytes in an in vitro culture system.Plasminogen activator inhibitor-1 modulates adipocyte differentiation.Impact of pioglitazone and bradykinin type 1 receptor antagonist on type 2 diabetes in high-fat diet-fed C57BL/6J mice.Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis.Degradation of STAT5 proteins in 3T3-L1 adipocytes is induced by TNF-{alpha} and cycloheximide in a manner independent of STAT5A activation.Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob/ob mice.A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses.Impact of biological therapy on body composition of patients with Chron's disease.Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes.Myokine IL-15 regulates the crosstalk of co-cultured porcine skeletal muscle satellite cells and preadipocytes.Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota.The Effects of Hesperidin and Quercetin on Serum Tumor Necrosis Factor-Alpha and Interleukin-6 Levels in Streptozotocin-induced Diabetes Model.The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats.
P2860
Q24795937-2F63C9B5-0997-47E3-83A4-8026E209A015Q26852403-FF341188-1A49-45CD-8998-81F281BBAD8AQ26865641-527026BC-4F25-4A1B-8C94-845D3C6DA6DAQ28261153-FA489DC5-89BC-4B89-A7A5-ACC657A0D837Q33546127-A8AD5827-1AB6-4531-A5D3-EC414BC72AC8Q33723738-EDF6B85C-A9A6-4A9F-B57E-B3BBF8EA515AQ33802207-E48300A7-C949-4BEE-B264-4F68883112B9Q34343619-6E153650-8A60-4785-AADD-94B4F7BF1962Q34442689-92AA6D82-DC3E-4A7F-8806-63AF33F03E4AQ34500690-AA8AFC35-1936-4230-B7F9-4681F0DA61B1Q35063263-616B0131-58FA-4E30-9E3D-330164988CF3Q35103678-214BB052-FA6E-4BBD-A123-FBA654EAEC48Q35750773-32D6783F-66B5-457D-8557-751008EC0225Q36030434-E254844A-B683-457A-BC12-A480450A2AA6Q36283524-2D6FEFF8-952D-4931-99C7-CD649B06A16DQ36360551-C7EED22F-A654-402E-8035-11EE2B8718C6Q36936432-D7E04B23-E883-4545-BCFC-BED7E576F473Q37021691-5C9628A9-3D25-4778-B42C-E76EA56C1BA8Q37154721-C65268A5-9DF2-4522-A957-40960A5ECBECQ37316455-7BD2CB0D-5521-4281-B735-DA286B836779Q37735170-A869A59C-882C-4F50-95AB-635CD342EA7CQ38539222-6F35F394-5F82-429E-876D-077E205E4966Q39330117-4E2021DB-07A9-40A8-9B2B-0C54ED4FF39CQ39395824-D1DB9AD7-8478-458F-9291-33102565D858Q40559827-4F1A72D9-A7C6-4838-981F-D8E76C0CE4E0Q40609811-505273E3-CF39-4498-BD56-88030305999EQ41862754-BA8AB347-B539-4BED-B5F9-4F57745864C4Q42096961-028A5AB2-871C-4AA0-B37C-39F5030D132FQ42483651-849692AD-1711-484F-BC08-A91532E1B5C3Q42740898-755578A8-E973-43EE-9A1A-AFCBB9DD406EQ42807673-AA8F2CF7-3C58-44D9-AC02-FC129928B895Q42835340-E55D2373-C042-4495-A57F-B51B74743CEAQ46174247-00791859-1AB9-476D-8A05-B86A35897602Q47272170-50A9D3AC-C999-4150-AED3-F7DF91E4DBB4Q50525563-298F7E48-8122-4E1B-BC36-B2B452196715Q51371762-F7BBD571-F47C-4DC6-A70A-16D0D1928AE9Q51421447-3293FCE6-9AA8-453F-87C2-93047AD19B05Q54920392-6B471A77-2DC3-4D78-B645-AA4EAF154B25Q55114561-D2BAA743-3D1A-40A7-BE35-B2569F90AC40Q55516074-8FDD44DF-785A-4298-923A-AA94FD7381AF
P2860
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
@ast
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
@en
type
label
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
@ast
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
@en
prefLabel
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
@ast
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
@en
P356
P1476
Tumour necrosis factor alpha: a key regulator of adipose tissue mass.
@en
P2093
P304
P356
10.1677/JOE.0.1770351
P407
P577
2003-06-01T00:00:00Z